Format

Send to

Choose Destination
Gut Microbes. 2014 Jan-Feb;5(1):5-10. doi: 10.4161/gmic.26749. Epub 2013 Oct 31.

Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease.

Author information

1
EA 4678 CIDAM; Clermont Université; Université d'Auvergne; Clermont-Ferrand, France.
2
EA 4678 CIDAM; Clermont Université; Université d'Auvergne; Clermont-Ferrand, France; Department of Microbiology and Alimentary Pharmabiotic Centre; University College Cork; Cork, Ireland.
3
Department of Microbiology and Alimentary Pharmabiotic Centre; University College Cork; Cork, Ireland.
4
Clermont Université; Université d'Auvergne - INRA; UMR 1019 UNH; Clermont-Ferrand, France.

Abstract

Trimethylamine (TMA) is produced by gut bacteria from dietary ingredients. In individuals with a hereditary defect in flavin-containing monooxygenase 3, bacterial TMA production is believed to contribute to the symptoms of trimethylaminuria (TMAU; fish-odor syndrome). Intestinal microbiota TMA metabolism may also modulate atherosclerosis risk by affecting trimethylamine oxide (TMAO) production levels. We propose that reducing TMA formation in the gut by converting it to an inert molecule could be used to prevent or limit these human diseases, while avoiding the major drawbacks of other clinical interventions. Reducing TMA levels by microbiological interventions could also be helpful in some vaginoses. Particular members of a recently discovered group of methanogens, that are variably present in the human gut, are unusual in being apparently restricted to utilizing only methyl compounds including TMA as substrates. We confirmed experimentally that one of these strains tested, Methanomassiliicoccus luminyensis B10, is able to deplete TMA, by reducing it with H 2 for methanogenesis. We therefore suggest that members of this archaeal lineage could be used as treatments for metabolic disorders.

KEYWORDS:

L-carnitine; Methanomassiliicoccusspp; TMA; TMAO; archaebiotics; cardiovascular disease (CVD); choline; thermoplasmata-related methanogens; trimethylaminuria (TMAU); vaginosis

PMID:
24247281
PMCID:
PMC4049937
DOI:
10.4161/gmic.26749
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center